Semiautomatic macroencapsulation of large numbers of porcine hepatocytes by coextrusion with a solution of AN69 polymer.

We have previously demonstrated that allogenic and xenogenic hepatocytes macroencapsulated manually in AN-69 polymer and transplanted intra-peritoneally in rats remained viable for several weeks. However, this manual technique is inadequate to encapsulate several billions of hepatocytes which would be required to correct hepatic failure in big animals or humans. In the present study, we developed an original semiautomatic device in which isolated pig hepatocytes and the polymer solution containing 6% poly(acrylonitrile-sodium methallylsulfonate), 91% dimethylsulfoxide and 3% 0.9% NaCl solution were coextruded through a double-lumen spinneret. The extruded minitube (inner diameter: 1.8 mm, wall thickness: 0.07-0.1 mm) containing the encapsulated hepatocytes fell and coiled up in a 0.9% NaCl solution at 4 degrees C and was cut down in 4 m units containing about 120 million hepatocytes. This process allowed to encapsulate 50 million hepatocytes by minute with a preserved immediate cell viability (92 +/- 5%). To test prolonged cell viability after coextrusion, the minitubes were implanted intraperitoneally in rats. Three and seven days after implantation, they were explanted and analyzed. Cells were viable and well-preserved. Therefore, the semiautomatic device appears able to efficiently macroencapsulate in a limited time several billions of porcine hepatocytes which remain viable after transplantation in xenogenic conditions.

[1]  H. Jauregui,et al.  Isolation and culture of porcine hepatocytes for artificial liver support. , 1996, Cell transplantation.

[2]  L. Podestá,et al.  A Bioartificial Liver to Treat Severe Acute Liver Failure , 1994, Annals of surgery.

[3]  S. Levenson,et al.  Transplantation of microcarrier‐attached hepatocytes into 90% partially hepatectomized rats , 1988, Hepatology.

[4]  V. Dixit.  Development of a bioartificial liver using isolated hepatocytes. , 1994, Artificial organs.

[5]  G. Reach,et al.  Glucose-insulin kinetics of a bioartificial pancreas made of an AN69 hydrogel hollow fiber containing porcine islets and implanted in diabetic mice. , 1998, Artificial organs.

[6]  B. Clement,et al.  Survival, proliferation, and functions of porcine hepatocytes encapsulated in coated alginate beads: a step toward a reliable bioartificial liver. , 1997, Transplantation.

[7]  R. Shatford,et al.  A technique for porcine hepatocyte harvest and description of differentiated metabolic functions in static culture. , 1995, Transplantation.

[8]  D. Samuel,et al.  Orthotopic Liver Transplantation in Fulminant and Subfulminant Hepatitis The Paul Brousse Experience , 1995, Annals of surgery.

[9]  R Williams,et al.  Extracorporeal support and hepatocyte transplantation in acute liver failure and cirrhosis , 1999, Journal of gastroenterology and hepatology.

[10]  D. Cooper,et al.  The Pig as Potential Organ Donor for Man , 1991 .

[11]  D. Ingber,et al.  Hollow Fibers for Hepatocyte Encapsulation and Transplantation: Studies of Survival and Function in Rats , 1994, Cell transplantation.

[12]  R. L. Broughton,et al.  Microencapsulation of mammalian cells in a HEMA-MMA copolymer: effects on capsule morphology and permeability. , 1990, Journal of biomedical materials research.

[13]  G. Abouna,et al.  Extracorporeal liver perfusion system for successful hepatic support pending liver regeneration or liver transplantation: a pre-clinical controlled trial. , 1999, Transplantation.

[14]  J. C. Fox,et al.  The pig as a potential organ donor for man. A study of potentially transferable disease from donor pig to recipient man. , 1994, Transplantation.

[15]  J. Kordower,et al.  Implants of Encapsulated Human CNTF-Producing Fibroblasts Prevent Behavioral Deficits and Striatal Degeneration in a Rodent Model of Huntington’s Disease , 1996, The Journal of Neuroscience.

[16]  B. Nordlinger,et al.  Internal bioartificial liver with xenogeneic hepatocytes prevents death from acute liver failure: an experimental study. , 1998, Annals of surgery.

[17]  M. Baudrimont,et al.  Transplantation intrapéritonéale d'hépatocytes isolés de porc: le foie bioartificiel implantable , 1998 .

[18]  A. Sheil,et al.  Comparison of porcine hepatocytes with human hepatoma (C3A) cells for use in a bioartificial liver support system. , 1998, Cell transplantation.

[19]  M V Peshwa,et al.  Formation of porcine hepatocyte spheroids for use in a bioartificial liver. , 1995, Cell transplantation.

[20]  Myriam Schluep,et al.  Intrathecal delivery of CNTF using encapsulated genetically modifiedxenogeneic cells in amyotrophic lateral sclerosis patients , 1996, Nature Medicine.

[21]  N. Sussman,et al.  Reversal of fulminant hepatic failure using an extracorporeal liver assist device , 1992, Hepatology.

[22]  B. Nordlinger,et al.  Permeability and biocompatibility of a new hydrogel used for encapsulation of hepatocytes. , 1995, Biomaterials.

[23]  J. Nobrega,et al.  HEMA/MMMA microcapsule implants in hemiparkinsonian rat brain: biocompatibility assessment using [3H]PK11195 as a marker for gliosis. , 1998, Biomaterials.

[24]  M. Sefton,et al.  Viability and protein secretion from human Hepatoma (HepG2) cells encapsulated in 400‐μm polyacrylate microcapsules by submerged nozzle–liquid jet extrusion , 1994, Biotechnology and bioengineering.

[25]  R. Fisher,et al.  Hepatocyte transplantation as a bridge to orthotopic liver transplantation in terminal liver failure. , 1997, Transplantation.

[26]  J. Chowdhury,et al.  Hepatocyte transplantation: Back to the future , 1992 .

[27]  M. Peschanski,et al.  Protective effect of encapsulated cells producing neurotrophic factor CNTF in a monkey model of Huntington's disease , 1997, Nature.

[28]  J. Rozga,et al.  In vitro morphological and functional characterization of isolated porcine hepatocytes for extracorporeal liver support: bile acid uptake and conjugation. , 1998, The Journal of surgical research.

[29]  Elie,et al.  Auxiliary liver transplantation: Regeneration of the native liver and outcome in 30 patients with fulminant hepatic failure–a multicenter European study , 1996, Hepatology.

[30]  P Aebischer,et al.  Macroencapsulation of dopamine-secreting cells by coextrusion with an organic polymer solution. , 1991, Biomaterials.

[31]  V. Maffettone,et al.  Liver transplantation in patients with fulminant hepatic failure , 1995, The British journal of surgery.

[32]  M. Sherman,et al.  Development and evaluation of a system of microencapsulation of primary rat hepatocytes , 1989, Hepatology.

[33]  B. Nordlinger,et al.  Evidence for survival and metabolic activity of encapsulated xenogeneic hepatocytes transplanted without immunosuppression in Gunn rats. , 1997, Transplantation.

[34]  B. Nordlinger,et al.  [Transplantation of allogeneic hepatocytes without immunosuppression: long term survival]. , 1994, Bulletin de l'Academie nationale de medecine.